Related Experiment Video

Updated: Apr 7, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.5K

Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives

Shawn J Rice, Bruce Miller, Matthias Wagman

  • 1Penn State Hershey Cancer Institute, Penn State College of Medicine, 500 University Dr, Hershey, PA 17033, USA. cbelani@hmc.psu.edu.

Current Molecular Pharmacology
|July 17, 2015
PubMed

Insights

New immunotherapies like cancer vaccines and cellular therapies offer hope for treating non-small cell lung cancer. These novel strategies show promise where traditional treatments have plateaued, improving patient outlook.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Lung cancer remains a leading cause of cancer-related mortality.
  • Current targeted therapies (e.g., erlotinib, crizotinib) have limited impact on long-term survival.
  • Novel therapeutic strategies are crucial for improving lung cancer treatment outcomes.

Purpose of the Study:

  • To review the current landscape of immunotherapy for non-small cell lung cancer (NSCLC).
  • To discuss the potential of cancer vaccines, immune checkpoint blockers, and adoptive cellular therapies.
  • To highlight the emerging role of immunotherapy in NSCLC management.

Main Methods:

  • Literature review of recent advancements in cancer immunotherapy.
  • Focus on clinical applications and trial outcomes for NSCLC.
  • Synthesis of data on novel treatment modalities.

Main Results:

  • Immunotherapy represents a rapidly advancing field with significant potential.
  • Cancer vaccines, immune checkpoint blockers, and adoptive cellular therapies are emerging as promising treatments.
  • A subset of patients demonstrates durable clinical activity with these novel approaches.

Conclusions:

  • Immunotherapy offers a new frontier in the management of non-small cell lung cancer.
  • These novel strategies provide optimism for improved patient survival and treatment efficacy.
  • Further research and clinical application of immunotherapies are warranted for lung cancer.

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K
A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer07:46

A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer

Published on: August 19, 2025

2.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K